Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol

NCT04726137 is registered in ClinicalTrials.gov with PENTA Foundation as lead sponsor.

NCT NCT04726137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04726137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol
Lead sponsor
PENTA Foundation
Phase
Observational
Overall status
Completed
Start date
October 14, 2020
Completion date
July 9, 2022
Enrollment
906 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2 antibodies in children and adolescents living with hiv